HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow’s human recombinant collagen platform for beauty and biomedical applications
JAVENÉ, France, May 6, 2024 /PRNewswire/ — HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company… Read More »HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow’s human recombinant collagen platform for beauty and biomedical applications



